Avelumab (Bavencio)

Avelumab · Merck KGaA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Avelumab (Bavencio), covering 2026-01-09 to 2026-01-09. Get the full timeline:

Most recent: Clinical Trial Update: Pemetrexed and Avelumab in Treating Patients With MTAP-Deficient Metastatic Urothelial Cancer [Phase 2]